MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Dat-SPECT in multiple system atrophy (MSA)

    I. Toyoshima, T. Hatakeyama, Y. Takeda, K. Obara, M. Kobsysdhi, C. Wada (Yurihonjo, Japan)

    Objective: To evaluate the extent of degeneration in dopamine nerve terminal in striatum with the patients with MSA, and compared between subtypes and disease duration…
  • 2016 International Congress

    Chronic acquired hepatocerebral degeneration: Efficacy of liver transplatation in 10 patients

    J. Martins, J. Alves, S. Cavaco, J. Gandara, S. Ferreira, H. Pessegueiro, M. Magalhães (Porto, Portugal)

    Objective: To determine the effect of liver transplantation (LT) on neurological symptoms in patients with chronic acquired hepatocerebral degeneration (CAHD). Background: CAHD is a rare…
  • 2016 International Congress

    Theta burst repetitive transcranial magnetic stimulation in a case with cortical-basal ganglionic degeneration

    A. Demirtas-Tatlidede, Z. Matur, B. Bilgic, H. Hanagasi, M. Emre, H. Gurvit, E. Oge (Istanbul, Turkey)

    Objective: Corticobasal ganglionic degeneration (CBGD) is a progressive taupathy involving frontal and parietal cortices as well as basal ganglia. The disease is clinically characterized by…
  • 2016 International Congress

    PROSPECT: A UK-based longitudinal observational study of PSP, CBD, MSA and atypical parkinsonism syndromes

    J. Woodside, R. Lamb, V. Chelban, D. Burn, A. Church, A. Gerhard, M. Hu, N. Leigh, J. Rowe, H. Houlden (London, United Kingdom)

    Objective: To aid the development of curative treatments, we need to develop better methods for diagnosing Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration (CBD) and Multiple…
  • 2016 International Congress

    Parkinsonism and movement disorders in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)

    I. Amorín, A. Lescano, A. Panuncio, V. Raggio, R. Buzó (Montevideo, Uruguay)

    Objective: To study and report the frequency of movement disorders in Cerebral Autosomal-Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL). Background: CADASIL is the main…
  • 2016 International Congress

    Parkinsonism in patients with CADASIL

    S.K. Song, J.H. Kang (Jeju-si, Korea)

    Objective: To report the clinical manifestation of parkinsonism in patient with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) confirmed by the NOTCH3…
  • 2016 International Congress

    Spinal fluid biomarkers for multiple system atrophy – A pilot study

    W. Singer, A. Schmeichel, D.M. Goldstein, J.D. Schmelzer, A.D. Zeller, T.L. Gehrking, P.A. Low (Rochester, MN, USA)

    Objective: To evaluate a comprehensive panel of cerebral spinal fluid (CSF) markers in multiple system atrophy (MSA) to define those with potential as future disease…
  • 2016 International Congress

    J-FIRST: First-in-Japan observational study of Parkinson’s disease treatments and nonmotor symptoms

    T. Maeda, Y. Shimo, S.W. Chiu, T. Yamaguchi, K. Kashihara, Y. Tsuboi, M. Nomoto, N. Hattori, H. Watanabe, H. Saiki (Akita, Japan)

    Objective: To clarify the clinical manifestations of nonmotor symptoms (NMSs) and identify factors affecting NMSs and quality of life (QOL) in Japanese patients with Parkinson's…
  • 2016 International Congress

    The relationship between the cognitive phenotype and 5-HT2A receptor in PD with visual hallucinations

    S.S. Cho, A.P. Strafella, S. Duff-Canning, M. Zurowski, A.C. Vijverman, V. Bruno, C. de Aquino, M. Criaud, P.M. Rusjan, S. Houle, S.H. Fox (Toronto, ON, Canada)

    Objective: The aim of this study was to investigate the relationship between cognitive phenotype and 5-HT2A receptor availability in PD patients with visual hallucinations (VH).…
  • 2016 International Congress

    Cognition, vision and visuo-cognition in gait in Parkinson’s disease

    S. Stuart, B. Galna, S. Lord, L. Rochester (Newcastle upon Tyne, United Kingdom)

    Objective: This study examined the selective but overlapping roles of cognition and vision in gait in Parkinson's disease (PD). To address this we studied; 1)…
  • « Previous Page
  • 1
  • …
  • 1372
  • 1373
  • 1374
  • 1375
  • 1376
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley